Given that acetyl-CoA is a key metabolic product of both glycolysis and lipid oxidation [15], these findings suggest that IL-8/CXCR2 signalling promotes metabolic reprogramming to fuel tumour progression. Here, CXCR2 is linked to neoplasm.